PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 37.5 CHF 4.46%
Market Cap: CHf1.2B

Wall Street
Price Targets

PPGN Price Targets Summary
PolyPeptide Group AG

Wall Street analysts forecast PPGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PPGN is 38.9 CHF with a low forecast of 33.33 CHF and a high forecast of 46.2 CHF.

Lowest
Price Target
33.33 CHF
11% Downside
Average
Price Target
38.9 CHF
4% Upside
Highest
Price Target
46.2 CHF
23% Upside
PolyPeptide Group AG Competitors:
Price Targets
GLSI
Greenwich Lifesciences Inc
86% Upside
DHR
Danaher Corp
33% Upside
BSRR
Sierra Bancorp
10% Upside
VLA
Valneva SE
133% Upside
TMO
Thermo Fisher Scientific Inc
27% Upside

Revenue
Forecast

12% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
12% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 6 years the compound annual growth rate for PolyPeptide Group AG's revenue is 12%. The projected CAGR for the next 3 years is 18%.

Operating Income
Forecast

-18% / Year
Past Growth
108% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
-18% / Year
Past Growth
108% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

For the last 6 years the compound annual growth rate for PolyPeptide Group AG's operating income is -18%. The projected CAGR for the next 3 years is 108%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PPGN's stock price target?
Price Target
38.9 CHF

According to Wall Street analysts, the average 1-year price target for PPGN is 38.9 CHF with a low forecast of 33.33 CHF and a high forecast of 46.2 CHF.

What is PolyPeptide Group AG's Revenue forecast?
Projected CAGR
18%

For the last 6 years the compound annual growth rate for PolyPeptide Group AG's revenue is 12%. The projected CAGR for the next 3 years is 18%.

What is PolyPeptide Group AG's Operating Income forecast?
Projected CAGR
108%

For the last 6 years the compound annual growth rate for PolyPeptide Group AG's operating income is -18%. The projected CAGR for the next 3 years is 108%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett